Group 1 - The company held its sixth temporary board meeting of the eighth board on September 10, 2025, with all six directors present, complying with legal and regulatory requirements [2][3]. - The board approved the proposal to amend the company's articles of association, eliminating the supervisory board and transferring its responsibilities to the audit committee under the board [3][39]. - The revised articles of association and governance documents will be submitted for shareholder approval [5][40]. Group 2 - The board approved multiple governance document amendments, including rules for shareholder meetings, board meetings, independent director work systems, and others, all requiring shareholder approval [6][8][11]. - The board proposed the election of three non-independent directors and three independent directors for the ninth board, with terms starting upon shareholder approval [16][21][24]. - The independent directors' remuneration was set at 60,000 yuan per year, subject to shareholder approval [26][27]. Group 3 - The board approved a proposal for expected related party transactions for 2025, which will also require shareholder approval [28][29]. - A second temporary shareholder meeting is scheduled for September 29, 2025, to review the proposals submitted by the board [30].

Meeting Overview - The shareholder meeting of Yifan Pharmaceutical Co., Ltd. was held on September 5, 2025, with both on-site and online voting options available [1][2] - A total of 305 shareholders and representatives participated, representing 523,447,918 shares, which is 43.0329% of the total voting shares [1] Voting Participation - Among the participants, 298 were small investors and authorized representatives, with 24,242,411 shares represented, accounting for 1.9930% of the total voting shares [2] Proposal Voting Results - The following proposals were approved during the meeting: Amendment of Company Articles - The proposal to amend the Articles of Association received 99.9397% approval, with 523,132,518 votes in favor [2] Amendment of Shareholder Meeting Rules - The proposal to amend the Rules of Procedure for Shareholder Meetings was approved with 98.2548% support, totaling 514,312,460 votes [3] Amendment of Board Meeting Rules - The proposal to amend the Rules of Procedure for Board Meetings was approved with 98.2528% support, totaling 514,302,460 votes [4] Amendment of Independent Director Work System - The proposal to amend the Independent Director Work System received 98.2537% approval, with 514,307,160 votes in favor [4] Amendment of Fund Management Measures - The proposal to amend the Fund Management Measures was approved with 98.2552% support, totaling 514,314,660 votes [5] Amendment of Related Party Transaction Decision-Making System - The proposal to amend the Related Party Transaction Decision-Making System received 98.2542% approval, with 514,309,760 votes in favor [6] Amendment of Investment Management System - The proposal to amend the Investment Management System was approved with 98.2539% support, totaling 514,307,960 votes [6] Amendment of Accountant Selection System - The proposal to amend the Accountant Selection System received 98.2544% approval, with 514,310,660 votes in favor [7] Adjustment of Independent Director Allowances - The proposal to adjust the allowances for independent directors was approved with 99.9303% support, totaling 523,083,218 votes [8] Election of Non-Independent Directors - The election of non-independent directors was approved with 97.2691% support, totaling 509,153,070 votes [8] Election of Independent Directors - The election of independent directors received 99.4032% approval, with 520,324,012 votes in favor [9] Legal Opinion - The meeting was witnessed by lawyers from Anhui Tianhe Law Firm, confirming that the meeting's procedures and resolutions complied with relevant laws and regulations [9]

Core Viewpoint - The company, Huayi Family Co., Ltd., has made significant governance changes by abolishing the supervisory board and revising various internal management systems to enhance operational efficiency and compliance with legal regulations [1][2][3]. Group 1: Governance Changes - The board of directors approved the cancellation of the supervisory board, transferring its powers to the audit committee of the board [1]. - The company will revise its articles of association and related governance documents to reflect these changes [1][2]. - The decision to abolish the supervisory board was made in accordance with the new Company Law and relevant regulations [1]. Group 2: Management System Revisions - The company has revised its external guarantee management system to align with legal requirements and its operational realities [2][3]. - The related party transaction decision-making system has also been updated to ensure compliance with the latest regulations [2][3]. - The fundraising management measures have been revised to improve governance and operational efficiency [3][4]. Group 3: Board of Directors Election - The company plans to elect a new board of directors, with a proposed composition of eight members, including three independent directors [5]. - The candidates for the eighth board of directors have been recommended and will be submitted for shareholder approval [5][6]. - The election is scheduled to take place during the second extraordinary general meeting of shareholders on September 22, 2025 [6]. Group 4: Additional Management Revisions - The company will revise several internal management systems to strengthen business management and governance [4]. - The revised systems include guidelines for various committees, internal audit procedures, and investor relations management [4].

Group 1 - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the election of the second board of directors [1][15][16] - The meeting will take place on September 11, 2025, at 14:30 in Huai'an, Jiangsu Province, and will combine on-site and online voting methods [6][13] - The company aims to ensure the legal rights of all shareholders and maintain order during the meeting, with specific registration and voting procedures outlined [2][4][5] Group 2 - Proposal 1 involves changing the company's business scope and amending the articles of association, specifically removing certain hazardous chemical operations [6][7] - Proposal 2 outlines the profit distribution plan for the first half of 2025, with a net profit of approximately 27.8 million yuan and a proposed cash dividend of 1.00 yuan per 10 shares, totaling 8.8 million yuan [13][14] - Proposals 3 and 4 focus on the election of non-independent and independent directors for the second board, with specific candidates nominated and their qualifications verified [15][16]

Core Viewpoint - The company is holding its second extraordinary general meeting of shareholders in 2025 to elect the eighth board of directors, including both non-independent and independent directors [5][6][7] Group 1: Meeting Procedures - The company has established guidelines to ensure the rights of all shareholders and the orderly conduct of the meeting, in accordance with relevant laws and regulations [1] - Shareholders and their representatives must sign in at least half an hour before the meeting and present necessary identification documents [2] - The meeting will follow the agenda as notified, allowing shareholders to exercise their rights to speak, inquire, and vote [3][4] Group 2: Election of Directors - The first proposal involves the election of three non-independent directors: Jin Xiaotuan, Zheng Jing, and Wang Qin, for a term of three years [6] - The second proposal includes the election of three independent directors: Gu Xinjian, Wu Xueyou, and Xu Fang, also for a term of three years [7] - The independent director candidates have varying qualifications, with two already holding independent director qualification certificates, while one is in the process of obtaining necessary training [7]

Group 1 - The company is holding a shareholders' meeting to ensure the rights of all shareholders and maintain order and efficiency during the meeting [1][2] - Attendance verification will be conducted for shareholders and their representatives, and latecomers will not be allowed to participate in voting [2][3] - The meeting will include a combination of on-site and online voting methods, with specific voting times outlined [5][6] Group 2 - The agenda includes the proposal to cancel the supervisory board and amend the company's articles of association, transferring the supervisory responsibilities to the audit committee of the board [6][8] - The company plans to elect a new board of directors, with specific candidates nominated for non-independent and independent director positions [9][12] - The meeting will conclude with the announcement of voting results and the signing of meeting records [7][8]

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss various proposals related to corporate governance and board elections [1][5][12] Group 1: Meeting Procedures - Shareholders and their proxies must arrive at the meeting venue half an hour before the start to complete registration and present necessary identification documents [2][4] - The meeting will follow a predetermined agenda, and shareholders have the right to speak, inquire, and vote [2][3] - Voting will be conducted through a combination of on-site and online methods, with results announced after counting [3][5] Group 2: Agenda Items - Proposal 1: Revision of the company's articles of association to enhance governance by abolishing the supervisory board and transferring its powers to the audit committee [6][8] - Proposal 2: Revision of the rules governing shareholder meetings to align with updated regulations [7][9] - Proposal 3: Revision of the rules governing board meetings to ensure compliance with legal standards [8][10] - Proposal 4: Revision of the director remuneration management system to improve governance [9][11] - Proposal 5: Revision of the related party transaction management system to protect investor rights [10][12] - Proposal 6: Revision of the external investment management system to mitigate investment risks [11][12] - Proposal 7: Revision of the external guarantee management system to ensure asset safety [11][12] - Proposal 8: Revision of the fundraising management system to enhance efficiency [12] - Proposal 9: Election of non-independent directors for the fourth board, with a total of 9 directors proposed [12][13] - Proposal 10: Election of independent directors for the fourth board, with 3 independent directors proposed [13][14]

Group 1 - The company held its 35th meeting of the 6th Board of Directors on September 1, 2025, via communication, with all 9 directors present, complying with relevant regulations [1] - The Board approved the election of non-independent director candidates for the 7th Board, including Xiao Zhanglin, Huang Junkang, Huang Guojun, Hu Min, and Guo Gaohang, with a unanimous vote of 9 in favor [1][2] - The Board also approved the election of independent director candidates, including Zeng Quan, Chen Liping, and Pan Shoupei, with a unanimous vote of 9 in favor [2] Group 2 - The Board approved the revision of the company's fundraising management system, which will be submitted for shareholder meeting review [2][3] - The Board agreed to change the lease contract with Shenzhen Zhonghang Guanlan Real Estate Development Co., Ltd., shortening the lease term to February 23, 2029, with a total transaction amount for the remaining contract period [3] - The Board proposed to hold the company's second extraordinary general meeting of shareholders in 2025, with a unanimous vote of 9 in favor [4] Group 3 - The resumes of the nominated candidates for the 7th Board of Directors were provided, detailing their qualifications and current positions [5][6][7][8][9][10][11][12][13][14][15]

Group 1 - The company held its 42nd meeting of the sixth board of directors on August 29, 2025, to discuss the election of the seventh board of directors [2][6][38] - The meeting was attended by all seven directors, and the chairman, Mr. Zhou Wen, presided over the meeting [3][4] - The board approved the election of three non-independent directors: Mr. Zhou Wen, Mr. Zhou Zhenlun, and Mr. Zhou Bing, with unanimous support of 7 votes [6][8][10] Group 2 - The board also approved the election of three independent directors: Mr. Qian Junlv, Mr. Tang Yunwei, and Mr. Shao Wanquan, with unanimous support of 7 votes [10][11][39] - The independent directors' qualifications are subject to review by the Shenzhen Stock Exchange before being submitted for shareholder approval [12][39] - The seventh board of directors will consist of 7 members, including 4 non-independent directors and 3 independent directors, with a term of three years starting from the date of shareholder approval [38][39] Group 3 - The board approved a proposal to adjust the governance structure by abolishing the supervisory board, transferring its powers to the audit committee of the board [13][14] - The company will revise its articles of association accordingly, with the revised articles to be disclosed in designated media [13][14] - The adjustments aim to enhance governance efficiency and streamline management processes [13][14] Group 4 - The board approved several internal governance system revisions, including amendments to the rules for shareholder meetings, board meetings, and independent director systems, all receiving unanimous support [15][16] - The company will also implement new management systems for various operational aspects, including external guarantees and investment management [15][16][20] - These revisions are intended to improve the company's operational standards and governance structure [15][16] Group 5 - The company plans to hold its third extraordinary general meeting of shareholders on September 15, 2025, to vote on the proposed board elections and governance adjustments [41][43] - The meeting will be conducted both in-person and via online voting, allowing shareholders to participate remotely [43][48] - Shareholders must register by September 9, 2025, to attend the meeting [44][47]

Group 1 - The company raised a total of approximately RMB 500 million through a specific stock issuance, with a net amount of approximately RMB 485.54 million after deducting issuance costs [2][3] - The issuance was approved by the China Securities Regulatory Commission on December 4, 2023, and the shares were priced at RMB 7.12 each [2] - The funds raised are intended for various projects, including replacing self-raised funds and supplementing working capital [3][4] Group 2 - As of June 30, 2025, the company had utilized approximately RMB 122,500 for a high-purity phosphoric acid project and temporarily supplemented working capital with idle funds amounting to approximately RMB 197.29 million [4][6] - The remaining balance in the fundraising account as of June 30, 2025, was approximately RMB 6.82 million [4] Group 3 - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure proper use and management of the raised funds [5][6] - The company has signed tripartite and quadripartite agreements with its subsidiaries and underwriters to ensure strict approval procedures for fund usage [6] Group 4 - There have been no changes to the fundraising investment projects or any transfers or replacements of these projects [8] - The company has disclosed all information regarding the use of raised funds in a timely and accurate manner, with no violations reported [9] Group 5 - The company reported a net profit of approximately RMB 456.55 million for the first half of 2025, with a proposed cash dividend of RMB 1.60 per 10 shares [75] - The total cash dividend is expected to amount to approximately RMB 154.74 million, with no stock dividends or capital reserve transfers planned [75] Group 6 - The company held its 24th meeting of the 8th Board of Directors on August 28, 2025, where several governance documents were revised and approved [71][79] - The company plans to hold its third extraordinary general meeting of 2025 on September 15, 2025, to discuss various proposals [79]